Drug Shortage Report for FORTAZ
| Report ID | 4301 |
| Drug Identification Number | 02212234 |
| Brand name | FORTAZ - INJ 6G/VIAL |
| Common or Proper name | Ceftazidime for injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFTAZIDIME |
| Strength(s) | 6G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 6's |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2017-07-20 |
| Estimated end date | |
| Actual end date | 2020-12-21 |
| Shortage status | Resolved |
| Updated date | 2020-12-22 |
| Company comments | This product has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.